• 1. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 2. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 3. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 4. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 5. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenoxyacetic acid derivatives

Recent Advances in the Study of 2-3-chloro-4-(trifluoromethyl)phenoxyacetic Acid (CAS: 886842-72-4)

The compound 2-3-chloro-4-(trifluoromethyl)phenoxyacetic acid (CAS: 886842-72-4) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, characterized by its trifluoromethyl and chloro-substituted phenoxyacetic acid structure, exhibits unique physicochemical properties that make it a promising candidate for various applications, including agrochemicals and pharmaceutical intermediates. Recent studies have focused on its synthesis, biological activity, and potential therapeutic uses, shedding light on its mechanism of action and optimization strategies.

One of the key areas of research has been the synthesis and structural modification of 2-3-chloro-4-(trifluoromethyl)phenoxyacetic acid to enhance its bioactivity. A study published in the Journal of Medicinal Chemistry (2023) reported a novel synthetic route that improves yield and purity while reducing environmental impact. The researchers employed a green chemistry approach, utilizing catalytic methods to minimize waste and energy consumption. This advancement not only facilitates large-scale production but also aligns with the growing demand for sustainable chemical processes in the pharmaceutical industry.

In addition to its synthetic optimization, the biological activity of 2-3-chloro-4-(trifluoromethyl)phenoxyacetic acid has been extensively investigated. Recent in vitro studies have demonstrated its potent herbicidal properties, particularly in targeting broadleaf weeds. The compound's mode of action involves the inhibition of auxin-like growth regulators, leading to uncontrolled cell division and eventual plant death. These findings, published in Pest Management Science (2024), highlight its potential as an effective and selective herbicide, offering an alternative to traditional agrochemicals with environmental concerns.

Beyond its agrochemical applications, preliminary research has explored the pharmaceutical potential of 2-3-chloro-4-(trifluoromethyl)phenoxyacetic acid. A study in Bioorganic & Medicinal Chemistry Letters (2023) investigated its role as a scaffold for developing anti-inflammatory agents. The compound's ability to modulate specific inflammatory pathways was attributed to its unique electronic and steric properties conferred by the trifluoromethyl group. Although further in vivo studies are needed, these results suggest a promising avenue for drug development, particularly in treating chronic inflammatory conditions.

Despite these advancements, challenges remain in the widespread application of 2-3-chloro-4-(trifluoromethyl)phenoxyacetic acid. Issues such as bioavailability, metabolic stability, and potential toxicity require thorough investigation. Recent toxicological studies, as reported in Regulatory Toxicology and Pharmacology (2024), have begun addressing these concerns by evaluating the compound's safety profile in mammalian models. The findings indicate a favorable toxicity profile at therapeutic doses, though long-term studies are necessary to ensure its suitability for human use.

In conclusion, the latest research on 2-3-chloro-4-(trifluoromethyl)phenoxyacetic acid (CAS: 886842-72-4) underscores its versatility and potential across multiple domains. From its optimized synthesis to its diverse biological activities, this compound represents a valuable subject of study for researchers in chemical biology and pharmaceutical sciences. Future directions may include further structural modifications to enhance specificity and efficacy, as well as comprehensive clinical trials to validate its therapeutic applications. As the field progresses, this molecule is poised to play a significant role in addressing both agricultural and medical challenges.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)